proteinas
sever
acut
respiratori
syndrom
sar
coronaviru
propos
key
target
structuralbas
drug
design
sar
accur
determin
dimer
dissoci
constant
role
nfinger
residu
provid
insight
enzym
catalyt
mechan
sar
proteinas
dimer
dissoci
constant
wildtyp
protein
determin
lm
analyt
ultracentrifug
method
nfinger
fragment
enzym
play
import
role
enzym
dimer
shown
crystal
structur
key
residu
nfinger
studi
sitedirect
mutagenesi
enzym
assay
analyt
ultracentrifug
singl
mutat
found
critic
maintain
dimer
structur
enzym
ntermin
octapeptid
mutant
also
synthes
test
potenc
dimer
inhibitor
peptid
cleavag
assay
confirm
peptid
dimer
inhibitor
k
mm
comparison
inhibitori
activ
mutant
indic
hydrophob
interact
electrostat
interact
contribut
inhibitor
bind
studi
describ
first
exampl
inhibitor
target
dimer
interfac
sar
proteinas
provid
novel
strategi
drug
design
sar
coronavirus
human
coronavirus
major
caus
upper
respiratori
tract
ill
human
novel
form
coronaviru
identifi
major
caus
sever
acut
respiratori
syndrom
sar
diseas
rapidli
spread
southern
china
sever
countri
coronavirus
member
positivestrand
rna
virus
featur
largest
viral
rna
genom
known
date
sar
coronaviru
replicas
gene
encompass
two
overlap
translat
product
polyprotein
kda
kda
conserv
length
amino
acid
sequenc
coronaviru
replicas
protein
polyprotein
cleav
intern
encod
proteinas
releas
function
protein
necessari
viru
replic
sar
proteinas
fulli
conserv
among
releas
sar
coronaviru
genom
sequenc
highli
homolog
coronaviru
proteinas
due
function
import
sar
proteinas
viral
life
cycl
propos
key
target
structuralbas
drug
design
sar
virtual
screen
chemic
compound
librari
discov
potenti
inhibitor
describ
variou
group
sever
bifunct
boron
acid
inhibitor
design
target
serin
cluster
near
catalyt
residu
peptid
analog
organ
compound
deriv
known
rhinoviru
proteas
inhibitor
also
synthes
found
activ
toward
sar
proteinas
crystal
structur
proteinas
sever
coronavirus
solv
dimer
enzym
shown
follow
gener
base
catalyt
mechan
report
previous
peptid
cleavag
assay
show
specif
activ
proteolysi
decreas
linearli
decreas
enzym
concentr
suggest
dimer
major
form
biolog
activ
dimer
interfac
could
target
structuralbas
drug
design
sar
proteinas
extra
helic
domain
sar
proteinas
also
shown
play
import
role
control
associationdissoci
equilibrium
regul
activ
specif
enzym
howev
publish
report
inhibitor
design
dimer
interfac
date
strategi
success
use
structurebas
inhibitor
design
human
immunodefici
viru
proteas
viral
enzym
proteas
homodim
two
ident
subunit
activ
site
gener
selfassembl
subunit
dimer
structur
stabil
extend
antiparallel
bsheet
form
interdigit
ntermin
residu
ctermin
residu
bstrand
monom
peptid
nand
ctermin
amino
acid
sequenc
design
confirm
dimer
inhibitor
larg
set
oligopeptid
deriv
termin
fragment
proteas
comput
model
inhibit
activ
determin
experiment
best
inhibitor
ic
valu
less
lm
crosslink
nand
ctermin
peptid
also
inhibit
proteas
activ
reduc
fraction
dimer
solut
measur
sizeexclus
chromatographi
design
dimer
inhibitor
also
report
mani
viral
enzym
hiv
revers
transcriptas
intergras
herp
simplex
viru
ribonucleotid
reductas
dna
polymeras
crystal
structur
sar
proteinas
indic
nfinger
fragment
play
import
role
dimer
mainten
activ
form
enzym
peptid
deriv
fragment
may
use
dimer
inhibitor
case
proteas
viral
enzym
present
paper
studi
key
residu
nfinger
sar
proteinas
sitedirect
mutagenesi
activ
test
analyt
ultracentrifug
ntermin
octapeptid
nine
mutant
also
synthes
test
inhibitori
activ
dimer
dissoci
constant
sar
proteinas
ntermin
mutant
determin
sediment
veloc
equilibrium
method
studi
provid
import
inform
structuralbas
inhibitor
design
target
dimer
interfac
sar
proteinas
provid
novel
strategi
drug
design
sar
coronavirus
express
purif
sar
proteinas
ctermin
histag
proteinas
express
purifi
describ
previous
nonhistag
proteinas
express
purifi
report
mutant
sarscov
proteinas
prepar
quikchang
sitedirect
mutagenesi
kit
stratagen
use
pet
templat
ntermin
delet
mutant
construct
insert
pcr
product
carri
nheihindiii
site
fragment
delet
codon
code
nheihindiiidigest
pet
dna
mutat
verifi
nucleotid
sequenc
purif
method
use
mutant
use
wildtyp
proteinas
puriti
verifi
sdspage
greater
peptid
synthesi
octapeptid
inhibitor
mutant
synthes
solidphas
peptid
synthesi
use
standard
chemistri
cleavag
peptid
rink
resin
remov
sidechainprotect
group
achiev
trifluoroacet
acid
solut
crude
peptid
purifi
reversedphas
highperform
liquid
chromatographi
rphplc
elit
dalian
china
zorbax
semiprepar
column
mm
agil
use
wateracetonitril
gradient
contain
trifluoroacet
acid
puriti
peptid
measur
analyt
rphplc
ident
confirm
matrixassist
laser
desorptionion
timeofflight
mass
spectroscopi
colorimetr
enzym
assay
enzym
activ
measur
colorimetr
assay
report
short
pna
substrat
stock
solut
mm
thrseralavalleuglnpna
water
solut
ad
preheat
reaction
buffer
mm
pb
mm
edta
mm
dtt
ph
contain
lm
enzym
colorimetr
measur
enzymat
activ
perform
microtit
plate
use
multiwel
ultraviolet
spectromet
spectra
max
molecular
devic
nm
assay
repeat
three
time
peptid
cleavag
assay
proteolyt
activ
histag
sar
proteinas
determin
use
hplcbase
peptid
cleavag
assay
previous
report
peptid
substrat
nh
tsavlqsgfrkconh
nh
savlqsgfconh
synthes
describ
previous
zhang
et
al
establish
zhangpoorman
plot
distinguish
dimer
inhibitor
competit
inhibitor
three
major
hypothes
model
bioactiv
dimer
enzym
equilibrium
inact
monomer
enzym
ii
inhibitor
bound
enzym
monom
iii
substrat
concentr
peptid
cleavag
assay
low
compar
k
dimer
enzym
zhangpoorman
plot
peptid
use
substrat
cleavag
reaction
mixtur
incub
room
temperatur
contain
lm
substrat
lm
histag
sar
proteinas
inhibitor
lm
peptid
lm
dtt
mm
trishcl
buffer
ph
room
temperatur
reaction
stop
min
ad
trifluoroacet
acid
aqueou
solut
analyz
describ
previous
inhibitor
peptid
dissolv
dmso
premix
histag
proteinas
h
cleavag
reaction
mixtur
lm
substrat
lm
histag
sar
proteinas
lm
inhibitor
peptid
lm
dtt
dmso
mm
trishcl
buffer
ph
incub
room
temperatur
aliquot
reaction
remov
everi
min
within
min
reaction
stop
addit
trifluoroacet
acid
aqueou
solut
reaction
mixtur
analyz
rphplc
describ
k
cat
k
determin
plot
substrat
peak
area
use
equat
pa
peak
area
substrat
peptid
c
e
total
concentr
histag
proteinas
c
experiment
constant
inhibitori
activ
peptid
estim
use
dimer
inhibitor
model
zhangpoorman
plot
dimer
inhibit
constant
k
thu
calcul
use
follow
equat
k
cat
k
appar
k
cat
k
without
inhibitor
concentr
inhibitor
analyt
ultracentrifug
analysi
sediment
equilibrium
veloc
experi
conduct
beckman
optima
xla
analyt
ultracentrifug
equip
absorb
optic
rotor
standard
sixsector
equilibrium
centerpiec
use
freshli
prepar
wildtyp
mutat
sar
proteinas
purifi
bufferexchang
use
gel
filtrat
column
superdex
gl
amersham
bioscienc
sediment
buffer
mm
phosphat
buffer
mm
nacl
mm
edta
mm
dtt
ph
molar
extinct
coeffici
nm
mgcm
densiti
sediment
buffer
gml
partial
specif
volum
mlg
molecular
weight
monom
da
calcul
base
amino
acid
composit
use
program
sednterp
http
wwwbbriorgrasmbrasmbhtml
sediment
veloc
experi
sampl
concentr
mgml
refer
solut
load
cell
rotor
temperatur
equilibr
rotor
speed
rpm
absorb
scan
nm
collect
time
interv
min
data
analyz
softwar
sedfit
version
g
sediment
equilibrium
experi
sampl
refer
solut
load
nitrogenflush
cell
follow
degass
nitrogen
flush
prior
seal
protein
equilibr
data
collect
three
rotor
speed
rpm
equilibrium
reach
typic
h
absorpt
data
collect
nm
use
radial
step
size
cm
record
averag
measur
radial
posit
determin
baselin
valu
cell
end
data
collect
time
rotor
speed
increas
rpm
h
absorb
deplet
meniscu
measur
dissoci
constant
determin
fit
monomerdim
equilibrium
model
use
originbas
data
analysi
softwar
beckman
xlaxli
beckman
instrument
beckman
coulter
fullerton
ca
data
differ
concentr
speed
combin
global
fit
sediment
experi
studi
aggreg
state
enzym
nativ
solut
condit
dilut
effect
exist
compar
gel
filtrat
auc
consid
reliabl
gel
filtrat
determin
protein
aggreg
state
sediment
veloc
provid
hydrodynam
inform
molecular
size
distribut
conform
chang
wherea
sediment
equilibrium
perfectli
character
thermodynam
selfassoci
system
determin
dissoci
constant
recent
peter
schuck
develop
method
analysi
protein
selfassoci
sediment
veloc
experi
order
get
reliabl
result
perform
sediment
veloc
equilibrium
experi
determin
dissoci
constant
sar
proteinas
determin
dissoci
constant
wildtyp
proteinas
tag
sediment
veloc
experi
wildtyp
enzym
conduct
nine
enzym
concentr
result
c
distribut
profil
show
concentrationdepend
peak
posit
monom
dimer
fig
clearli
indic
fast
revers
associ
sar
proteinas
isotherm
analysi
w
c
shown
fig
base
integr
differenti
sediment
coeffici
c
distribut
fit
monomerdim
equilibrium
sedphat
program
dissoci
constant
determin
lm
monom
raw
data
circl
obtain
integr
differenti
sediment
coeffici
c
distribut
nine
enzym
concentr
sedphat
program
use
fit
data
monomerdim
equilibrium
solid
line
result
monom
sediment
coeffici
dimer
sediment
coeffici
dissoci
constant
k
lm
sediment
coeffici
dimer
sediment
coeffici
fig
sediment
equilibrium
experi
perform
three
differ
protein
concentr
mgml
three
run
speed
rpm
fig
show
result
global
fit
data
monomerdim
equilibrium
beckman
originbas
data
analysi
softwar
dissoci
constant
monomerdim
selfassoci
model
determin
k
lm
agreement
valu
sediment
veloc
experi
sinc
sediment
veloc
method
good
initi
explor
character
selfassoci
protein
take
final
k
lm
global
fit
sediment
equilibrium
data
sever
report
quantit
measur
dimer
dissoci
constant
sar
proteinas
analyt
ultracentrifug
enzym
activitydepend
assay
publish
dissoci
constant
larg
variat
differ
group
andor
use
protein
express
differ
construct
chou
et
al
report
dissoci
constant
nm
use
sediment
veloc
method
ctermin
histag
form
sar
proteinas
hsu
et
al
report
dissoci
constant
nm
use
sediment
veloc
method
wildtyp
protein
tag
sediment
equilibrium
experi
give
dissoci
constant
lm
wildtyp
protein
tag
one
extra
alanin
residu
nterminu
gener
speak
sediment
equilibrium
test
provid
firstprincipl
analysi
dissoci
constant
compar
sediment
veloc
method
crystal
structur
sar
proteinas
suggest
nfinger
fragment
contribut
significantli
enzym
dimer
experi
show
nfinger
delet
mutant
could
form
dimer
fig
agre
previou
report
nfinger
delet
mutant
monomer
form
solut
howev
seven
residu
nfinger
contribut
differ
dimer
stabil
fig
see
side
chain
point
away
dimer
interfac
interior
monom
remark
interact
two
import
residu
among
seven
guanidyl
group
one
monom
form
salt
bridg
side
chain
monom
one
major
interact
two
monom
furthermor
side
chain
form
hydrophob
interact
side
chain
partner
suggest
residu
two
possibl
key
residu
nfinger
role
dimer
stabil
howev
chou
et
al
report
mutat
partli
affect
dimer
sar
proteinas
keep
enzymat
activ
mean
might
domin
factor
dimer
interfac
studi
mutant
shown
weak
dimer
accord
sediment
experi
fig
e
detect
enzym
activ
either
tabl
substitut
posit
charg
neg
charg
glu
make
imposs
form
salt
bridg
monom
even
caus
charg
repuls
mutat
suggest
hydrophob
interact
side
chain
monom
contribut
significantli
stabil
dimer
studi
confirm
nfinger
play
import
role
stabil
dimer
sar
proteinas
nfinger
one
monom
import
enzym
activ
monom
easi
understand
phenomenon
dimer
activ
mutat
kept
enzym
activ
affect
dimer
sever
mean
electrostat
interact
contribut
salt
bridg
may
vital
dimer
howev
alanin
substitut
would
lethal
dimer
fact
conserv
substitut
lysin
valin
sever
coronaviru
proteinas
highli
conserv
leu
substitut
case
singl
ala
mutat
make
enzym
mostli
monom
detect
activ
hydrophob
effect
play
key
role
dimer
sinc
dimer
sar
proteinas
necessari
enzym
activ
interfac
dimer
may
use
new
target
structurebas
drug
design
ntermin
mutat
analysi
propos
hydrophob
group
acid
moieti
form
strong
hydrogen
bond
essenti
design
strong
dimer
interfac
bind
inhibitor
nfinger
fragment
octapeptid
dimer
inhibitor
sar
proteinas
crystal
structur
sar
proteinas
indic
nfinger
fragment
contribut
significantli
enzym
dimer
may
act
dimer
inhibitor
enzym
case
hiv
proteinas
viral
enzym
determin
whether
nfinger
fragment
inhibitori
toward
sar
proteinas
synthes
octapeptid
correspond
ntermin
residu
enzym
peptid
inhibitor
peptid
mutant
premix
histag
enzym
peptid
cleavag
assay
h
peptid
obviou
inhibitori
activ
millimolar
level
shown
tabl
chang
reaction
rate
caus
mainli
chang
appar
k
cat
appar
k
histag
proteinas
chang
littl
differ
concentr
indic
peptid
work
noncompetit
inhibitor
word
peptid
bind
site
distinct
substrat
pocket
differ
enzym
conform
zhang
et
al
establish
zhangpoorman
analysi
distinguish
dimer
inhibitor
competit
inhibitor
plot
c
e
ffiffiffiffiffiffiffi
ffi
k
exp
p
vs
ffiffiffiffiffiffiffi
ffi
k
exp
p
research
dimer
inhibitor
hiv
proteas
zhangpoorman
analysi
dimer
inhibitor
alter
yintercept
valu
factor
k
effect
slope
dimer
inhibitor
easili
identifi
use
zhangpoorman
plot
provid
line
parallel
proteas
alon
competit
noncompetit
inhibitor
give
nonparallel
line
zhangpoorman
plot
success
appli
mani
proteas
dimer
inhibitor
studi
fig
show
line
presenc
mm
peptid
parallel
absenc
inhibitor
strongli
suggest
inhibitor
peptid
dimer
inhibitor
sar
proteinas
prevent
enzym
proteolysi
activ
disturb
dimer
proteinas
sar
proteinas
propos
key
target
structuralbas
drug
design
sar
function
import
viral
life
cycl
howev
publish
report
inhibitor
design
target
proteinas
base
substrat
bind
pocket
serin
cluster
near
report
inhibitor
design
target
dimer
interfac
date
octapeptid
first
inhibitor
design
bind
dimer
interfac
coronaviru
proteinas
thu
provid
novel
strategi
drug
design
sar
coronavirus
investig
inhibit
mechan
nine
mutant
synthes
inhibitori
activ
determin
see
tabl
accord
mutat
studi
mutant
disrupt
dimer
structur
peptid
inhibitor
mutat
ala
peptid
complet
abolish
inhibitori
activ
singl
mutat
peptid
also
decreas
inhibit
activ
significantli
result
correl
well
mutat
studi
interest
peptid
contain
doubl
mutat
ala
ala
show
inhibitori
activ
even
though
predict
inact
base
result
singl
mutant
sinc
nfinger
fragment
adopt
extend
conform
crystal
structur
side
chain
point
outward
dimer
interfac
particip
enzym
dimer
mutat
ala
peptid
slightli
decreas
inhibit
activ
nfinger
fragment
indic
contribut
littl
inhibitor
bind
howev
peptid
peptid
backbon
may
turn
around
take
place
interact
enzym
due
loss
conform
restrict
offer
origin
confirm
triplemut
peptid
show
littl
inhibit
activ
summari
carri
mutat
studi
nfinger
sar
proteinas
determin
dimer
dissoci
constant
wildtyp
protein
mutant
use
sediment
veloc
equilibrium
techniqu
residu
found
essenti
maintain
dimer
structur
contribut
less
nfinger
octapeptid
synthes
confirm
dimer
inhibitor
k
mm
sever
peptid
mutant
also
synthes
test
inhibit
activ
hydrophob
interact
electrostat
interact
parallel
lower
line
indic
inhibitor
dimer
inhibitor
proteinas
prevent
enzym
proteolysi
activ
disturb
natur
proteinas
dimer
play
import
role
inhibitor
bind
peptid
first
inhibitor
design
target
dimer
interfac
coronaviru
proteinas
current
studi
provid
novel
strategi
drug
design
sar
coronavirus
